Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of Allergy and Infectious Diseases (5P01AI118688-04)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1F30DK123915-01)
  • Chan Zuckerberg Biohub
  • National Institute of General Medical Sciences (5T32GM007618-42)
  • Howard Hughes Medical Institute
  • The Rockefeller University
  • St. Giles Foundation
  • National Institutes of Health (R01AI088364)
  • National Center for Advancing Translational Sciences
  • NIH Clinical and Translational Science Award (UL1 TR001866)
  • Fast Grant from Emergent Ventures
  • Yale Center for Mendelian Genomics and the GSP Coordinating Center funded by the National Human Genome Research Institute (UM1HG006504 and U24HG008956)
  • Fisher Center for Alzheimer’s Research Foundation
  • Meyer Foundation
  • French National Research Agency (ANR) under the “Investments for the Future” program (ANR-10-IAHU-01)
  • Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID)
  • French Foundation for Medical Research (EQU201903007798)
  • RM and ANR GENCOVID project
  • ANRS-COV05
  • Square Foundation
  • Grandir - Fonds de solidarité pour l’enfance
  • SCOR Corporate Foundation for Science
  • Institut National de la Santé et de la Recherche Médicale
  • University of Paris